Jonera, with its effective formulation specially developed for cats, supports joint health and helps relieve pain associated with joint problems.
- UC-II induces oral tolerance through Peyer’s patches, specifically modulating the autoimmune T-cell response to cartilage antigens and reducing cartilage breakdown (catabolism).
- PEA regulates neurogenic pain and chronic inflammation by modulating the activation of mast cells and glial cells, which play key roles in nervous system–related pain and inflammation.
- ASU slows cartilage breakdown by suppressing catabolic effects on cartilage metabolism and reduces the production of the pro-inflammatory molecule nitric oxide (NO).
- A combination of GAG precursors and components supports both the formation and breakdown cycles involved in cartilage turnover. It increases the cartilage matrix’s capacity to bind and retain water by creating a negative charge within the matrix.
- It stimulates chondrocyte function while supporting both the proteoglycan and fibrous collagen components of the matrix, providing comprehensive structural repair.
- It improves synovial fluid quality, reduces inflammation within the joint capsule, and supports chondroprotective effects. By inhibiting fibrin and kinin formation, it reduces swelling and edema around the joints.
- Devil’s claw (harpagosides), PEA, Boswellia, and MSM support multimodal pain management.